showed a trendP = 0.2
Using a median cutoff of 4 cells/mm 2 to detect B cell–infiltrated tumors ( 21 ), we showed a trend toward improved OS in CD20 + -infiltrated tumors pre-NACT (median survival: 37.7 vs. 47.1 months; low vs. high B-cell infiltrated; P = 0.2 log-rank test).